União Química Farmacêutica Nacional S/A
🇺🇸United States
Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Study With Heparin Sodium in Intravenous Administration
Phase 1
Suspended
- Conditions
- Heparin
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2019-10-15
- Lead Sponsor
- União Química Farmacêutica Nacional S/A
- Target Recruit Count
- 24
- Registration Number
- NCT03125187
- Locations
- 🇧🇷
União Química Farmacêutica Nacional, São Paulo, Brazil
Study of Amblyomin-X in Advanced Solid Tumor
Phase 1
Suspended
- Conditions
- Advanced Cancer
- First Posted Date
- 2017-04-19
- Last Posted Date
- 2019-10-14
- Lead Sponsor
- União Química Farmacêutica Nacional S/A
- Target Recruit Count
- 24
- Registration Number
- NCT03120130
- Locations
- 🇧🇷
União Química Farmacêutica Nacional, Sao Paulo, SP, Brazil
Study With Heparin Sodium in Subcutaneous Administration
Phase 1
Suspended
- Conditions
- Heparin
- First Posted Date
- 2017-04-13
- Last Posted Date
- 2019-10-14
- Lead Sponsor
- União Química Farmacêutica Nacional S/A
- Target Recruit Count
- 38
- Registration Number
- NCT03113084
- Locations
- 🇧🇷
União Química Farmacêutica Nacional, São Paulo, Brazil
News
No news found